LAUREN GOODHUE: Open Payments
NPI 1306405154 · BEAUMONT, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$618 in 28 payments from 11 companies in 2025. Trend: 2023 $643 · 2024 $545 · 2025 $618
Food & beverage: $618
| Company | Payments | Amount |
|---|---|---|
| Merck Sharp & Dohme LLC | 9 | $205 |
| Actelion Pharmaceuticals US, Inc. | 4 | $121 |
| Inspire Medical Systems, Inc. | 3 | $79 |
| E.R. Squibb & Sons, L.L.C. | 4 | $67 |
| Novartis Pharmaceuticals Corporation | 2 | $32 |
| Innovation Technologies Inc | 1 | $28 |
| Kestra Medical Technology Services, Inc. | 1 | $23 |
| PFIZER INC. | 1 | $22 |
| Amgen Inc. | 1 | $19 |
| AstraZeneca Pharmaceuticals LP | 1 | $14 |
Products named: VERQUVO, OPSUMIT, INSPIRE, CAMZYOS, OPSYNVI, IRRISEPT, CAPVAXIVE, WINREVAIR.
Industry payments across TX — which companies pay providers there.
